Abstract | OBJECTIVE: METHODS: Women who were infected with HIV from January 1, 1998, to January 8, 2004, and who had a 1-hour and 3-hour glucola test were identified. Medical records were reviewed to obtain demographic characteristics and obstetric and laboratory data. Drug regimens at the time of glucola testing were determined. Human immunodeficiency virus-infected women were then matched 1:3 to HIV-noninfected gravidas by race, age, and year of delivery. RESULTS: One hundred seventy-one HIV-infected women had glucola results available. Twelve percent had an abnormal 1-hour glucola result and 3% had an abnormal 3-hour result. This was similar to the HIV-noninfected population. Forty-five percent of the HIV-infected cohort was on a protease inhibitor at the time of glucola testing. Protease inhibitor exposure had no effect on glucola test results. HIV infection itself also did not increase abnormal glucola test results. CONCLUSION:
|
Authors | Jennifer H Tang, Jeanne S Sheffield, Julie Grimes, Barbara McElwee, Scott W Roberts, Vanessa Laibl, Donald D McIntire, George D Wendel Jr |
Journal | Obstetrics and gynecology
(Obstet Gynecol)
Vol. 107
Issue 5
Pg. 1115-9
(May 2006)
ISSN: 0029-7844 [Print] United States |
PMID | 16648418
(Publication Type: Journal Article)
|
Chemical References |
|
Topics |
- Adult
- Antiretroviral Therapy, Highly Active
- Cohort Studies
- Female
- Glucose Intolerance
(etiology)
- Glucose Tolerance Test
- HIV Infections
(drug therapy)
- HIV Protease Inhibitors
(therapeutic use)
- Humans
- Pregnancy
- Pregnancy Complications, Infectious
(drug therapy)
- Prenatal Care
- Retrospective Studies
|